Percentages of CD5+CD19+ CLL cells, measured by flow cytometry, increased transiently in JAK2007, who otherwise had normal blood lymphocyte counts (Figure 2B). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.